How Medpace Holdings makes money

Period

FY2025

How does Medpace Holdings make money? This Sankey traces every dollar of revenue through the income statement — into cost of revenue, R&D, SG&A, and taxes — and shows what's left as profit. Pick any fiscal year, recent quarter, or the trailing twelve months. Straight from SEC filings.

Medpace Holdings Inc. · FY2025 · year ended 2025-12-31

Revenue$2.5BGross profit$2.5B · 100%Cost of revenue$0 · 0%Operating income$542M · 21%Operating expenses$2.0B · 79%SG&A$198M · 8%Other opex$1.8B · 71%Net income$451M · 18%Income tax$91M · 4%Oncology$748M · 30%Metabolic$745M · 29%Other$409M · 16%Central Nervous System$255M · 10%Cardiology$239M · 9%Antiviral & Anti Infective$135M · 5%

Each fiscal year from SEC filings. Percentages are share of revenue, so the green profit nodes read directly as gross / operating / net margin. Line items a company doesn't break out are derived from their siblings so the flows balance; small residuals show as “Other.” For informational purposes only.